There has been an increase in medicinal cannabis (MC) prescribing and an expansion of pharmacist’s responsibility to ensure its safe and effective use. Based on incident reports and professional practice enquiries from the past year, PDL has identified several key areas of risk associated with the…

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article
Extended scope of practice – a reminder to NSW pharmacists and pharmacy owners
13 February 2025
NSWProfessional activitiesScope of practice
Learn more